Skip to main content
. 2013 Apr 23;21(5):1096–1103. doi: 10.1038/mt.2013.32

Figure 1.

Figure 1

p53 transgene tumor expression. (a) DNA PCR assessment of the presence of exogenous p53 in three patients' tumors in comparison to negative and positive controls. (b) A separate experiment with just patients 1 and 2 at higher exposure to confirm that exogenous p53 is present in the tumor from the patient who received the 0.6 mg dose. T1: Biopsy was done 100 hours after last treatment (patient 02-007). T2: Biopsy was done 26 hours later (patient 02-011). T3: Biopsy was done 73 hours later (patient 02-014). N: The normal skin sample was taken 71 hours after last dose of SGT-53 (patient 02-014).